Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-30

Clinical Trial Update: Eniluracil Hand Foot Syndrome [Phase 1]

View source ↗

Summary

The Phase 1 trial of eniluracil for breast cancer and colon cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eniluracil (eniluracil)

Snippet

Sponsor: West Virginia University | Conditions: Breast Cancer, Colon Cancer | Phase 1 | Status: TERMINATED